Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence
- PMID: 25960725
- PMCID: PMC4395817
- DOI: 10.1159/000369845
Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence
Abstract
Radiation therapy delivered with hypofractionation, which involves the delivery of a higher dose per fraction in fewer fractions (generally with a lower total nominal dose) over a shorter overall treatment time, is an established therapeutic option at least for a selected group of early breast cancer patients after breast-conserving surgery. Optimal delivery of the tumor bed boost dose in terms of timing, fractionation, and total dose whenever a hypofractionated schedule is employed has yet to be established. We herein present a review of the current evidence on the role of boost integration in whole breast radiotherapy.
Keywords: Adjuvant whole breast radiotherapy; Breast cancer; Concomitant boost; Hypofractionation; IGRT; IMRT; Simultaneous integrated boost.
Figures
References
-
- Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol. 2007;84:84–101. - PubMed
-
- Graham P, Fourquet A. Placing the boost in the breast conservation radiotherapy: a review of the role, indications and techniques for breast boost radiotherapy. Clin Oncol (R Coll Radiol) 2006;18:210–219. - PubMed
-
- Freedman GM, White J, Arthur DW, et al. Accelerated fractionation with a concurrent boost for early stage breast cancer. Radiother Oncol. 2013;106:15–20. - PubMed
-
- Early Breast Cancer Trialists’ Collaborative Group: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087–2106. - PubMed
-
- Denham JW. The radiation dose-response relationship for control of primary breast cancer. Radiother Oncol. 1986;7:107–123. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
